Scholar Rock Holding (SRRK) Asset Utilization Ratio (2019 - 2022)
Scholar Rock Holding's (SRRK) quarterly Asset Utilization Ratio came in at 0.09 in Q4 2022, up 42.08% year-on-year from 0.06 in Q4 2021, and down 3.02% quarter-over-quarter from 0.09 in Q3 2022.
Scholar Rock Holding (SRRK) Asset Utilization Ratio (2019 - 2022) Analysis & Trends
Scholar Rock Holding's Asset Utilization Ratio history runs 4 years deep, the most recent figure standing at 0.09 for Q4 2022.
- On a quarterly basis, Asset Utilization Ratio rose 42.08% year-over-year to 0.09 in Q4 2022; TTM through Dec 2022 was 0.09, a 42.08% increase from a year earlier, with the FY2022 full-year figure at 0.1, up 84.43% from the prior year.
- Asset Utilization Ratio eased to 0.09 in Q4 2022 per SRRK's latest filing, from 0.09 in the prior quarter.
- Across five years, Asset Utilization Ratio topped out at 0.17 in Q1 2022 and bottomed at 0.04 in Q1 2021.
- The 4-year median for Asset Utilization Ratio is 0.09 (2022), against an average of 0.09.
- Across the five-year window, Asset Utilization Ratio tumbled 66.57% in 2021 and soared 311.78% in 2022, its largest moves.
- Year by year, Asset Utilization Ratio stood at 0.11 in 2019, then slumped by 47.56% to 0.06 in 2020, then increased by 11.8% to 0.06 in 2021, then soared by 42.08% to 0.09 in 2022.
- Per Business Quant, the three latest SRRK Asset Utilization Ratio figures stand at 0.09 (Q4 2022), 0.09 (Q3 2022), and 0.12 (Q2 2022).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.69 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 0.47 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 0.37 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Scholar Rock Holding | 6.30 Bn | 6.30 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 0.09 |
| Sep 30, 2022 | 0.09 |
| Jun 30, 2022 | 0.12 |
| Mar 31, 2022 | 0.17 |
| Dec 31, 2021 | 0.06 |
| Sep 30, 2021 | 0.06 |
| Jun 30, 2021 | 0.05 |
| Mar 31, 2021 | 0.04 |
| Dec 31, 2020 | 0.06 |
| Sep 30, 2020 | 0.12 |
| Jun 30, 2020 | 0.13 |
| Mar 31, 2020 | 0.12 |
| Dec 31, 2019 | 0.11 |
| Sep 30, 2019 | 0.07 |
| Jun 30, 2019 | 0.04 |